Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|June 4, 2014
Review of the quality of observational studies of the association between rosiglitazone and acute myocardial infarctionNigel S B RawsonCanadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 7, 2010
The aging male population and medical care for benign prostatic hyperplasia in CanadaNigel S B Rawson, Fred SaadDrug Safety|May 2, 2018
Healthcare Databases for Drug Safety Research: Data Validity Assessment Remains CrucialNigel S B Rawson, Carl D'ArcyHealthcarepapers|July 7, 2023
Canadians Need Improved Access to Drugs for Rare Diseases, Not More DenialNigel S B Rawson, John AdamsCurrent Oncology (Toronto, Ont.)|September 27, 2024
Is Canada Moving towards a More Agile Regulatory Approval and Reimbursement Process with a Shifting Role for Real-World Evidence (RWE) for Oncology Drugs?Catherine Y Lau, Nigel S B RawsonThe Annals of Pharmacotherapy|October 2, 2003
Canadian and US drug approval times and safety considerationsNigel S B Rawson, Kenneth I KaitinClinicoeconomics and Outcomes Research : CEOR|May 30, 2024
Timeliness of Health Technology Assessments and Price Negotiations for Oncology Drugs in CanadaNigel S B Rawson, David J StewartBMC Research Notes|March 19, 2013
Rosiglitazone use and associated adverse event rates in Canada between 2004 and 2010Nigel S B Rawson, Jorge A Ross TerresJournal of Clinical Epidemiology|January 8, 2008
Manitoba and Saskatchewan administrative health care utilization databases are used differently to answer epidemiologic research questionsAndrea C Tricco, Ba' Pham, Nigel S B RawsonThe Canadian Journal of Cardiology|February 5, 2002
New use of antiarrhythmia drugs in SaskatchewanNigel S B Rawson, Jafna L Cox, MaryRose Stang, et al.Pageof 4